Medical Xpress news

Medical Xpress / Key gut protein balances immune protection and tolerance

A protein produced by gut immune cells orchestrates both immune protection against pathogens and immune tolerance of gut bacteria, according to a study led by Weill Cornell Medicine investigators. The discovery illuminates ...

23 hours ago
Medical Xpress / New drug against metastatic prostate cancer made entirely from human proteins

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published ...

14 hours ago
Medical Xpress / The silent hormone: How adrenal tumors quietly raise cardiovascular risk over time

A major new study, published in The Lancet Diabetes & Endocrinology, has shown that cortisol levels in patients with adrenal tumors are far less stable than previously assumed. The study also found that those in whom cortisol ...

18 hours ago
Medical Xpress / Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients with B-cell ALL

Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival ...

20 hours ago
Medical Xpress / Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to ...

19 hours ago
Medical Xpress / Should older men reassess their long-term prostate medications?

One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these ...

21 hours ago
Medical Xpress / Common thyroid hormone may help prevent brain tumor relapse in children, says study

Researchers from Fox Chase Cancer Center have identified a widely used thyroid hormone that may significantly improve treatment outcomes for medulloblastoma, the most common malignant brain tumor in children. The study found ...

22 hours ago
Medical Xpress / Advanced imaging uncovers 3D nerve architecture inside rat knee joints, could yield clarity on jaw joint disorders

Temporomandibular disorders (TMDs) are a group of more than 30 conditions that cause pain and dysfunction in the jaw. So what could a small tissue sample from a rat's knee have to do with treating them?

20 hours ago
Medical Xpress / How immune cells in our gut mesentery fight salmonella

Widely recognized as the face of food poisoning, salmonella bacteria lurk in raw meat and poultry, on pets, and in unpasteurized dairy products. If untreated, extreme cases can lead to full-body infections, like typhoid fever. ...

19 hours ago
Medical Xpress / Clinical trial offers strong evidence that nerve blocks can cut opioid use after cardiac surgery

A clinical trial led by St. Michael's Hospital researchers found that using nerve blocks, an anesthesia technique to numb targeted areas of the body, significantly reduced opioid use after cardiac surgery—findings the authors ...

23 hours ago
Medical Xpress / Training device expands access to high-performance diagnostic testing

The rise of automation and AI has raised fears about job loss, but smart tools can also train workers rather than replace them. Meanwhile, a chronic shortage of trained personnel limits the reach of health care in both developing ...

Jul 7, 2026
Medical Xpress / Not all birth controls are equal, some are linked to higher risk of brain tumors, study finds

Meningiomas are the most common brain tumors in adults, accounting for 38% to 42% of all primary central nervous system tumors. According to 2021 WHO data, 874 million of the world's 1.9 billion women of reproductive age ...

Jul 7, 2026